Abstract.
Alzheimer’s disease (AD) is a neurodegenerative disorder associated with cognitive and behavioral dysfunction and is the leading cause of dementia in the elderly. Several studies have implicated molecular and cellular signaling cascades involving the serine-threonine kinase, glycogen synthase kinase β(GSK-3β) in the pathogenesis of AD. GSK-3β may play an important role in the formation of neurofibrillary tangles and senile plaques, the two classical pathological hallmarks of AD. In this review, we discuss the interaction between GSK-3β and several key molecules involved in AD, including the presenilins, amyloid precursor protein, tau, and β-amyloid. We identify the signal transduction pathways involved in the pathogenesis of AD, including Wnt, Notch, and the PI3 kinase/Akt pathway. These may be potential therapeutic targets in AD.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 19 December 2005; received after revision 24 January 2006; accepted 6 February 2006
Rights and permissions
About this article
Cite this article
Balaraman, Y., Limaye, A.R., Levey, A.I. et al. Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance. Cell. Mol. Life Sci. 63, 1226–1235 (2006). https://doi.org/10.1007/s00018-005-5597-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-005-5597-y